查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1606438

微針流感疫苗市場，按產品類型、按疫苗類型、按應用、按國家和地區 - 2024-2032 年行業分析、市場應用、市場佔有率和預測

Microneedle Flu Vaccine Market, By Product Type, By Vaccine Type, By Application, By Country, and By Region - Industry Analysis, Market Application, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 288 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告要點

2023年微針流感疫苗市場應用價值為16.3043億美元，2024年至2032年複合年成長率為6.30%。

微針流感疫苗市場-市場動態

對加強疫苗輸送和無針注射的需求不斷增加預計將推動市場需求

微針流感疫苗透過皮內注射增強免疫反應。對更有效和對患者友好的疫苗技術的興趣增加。無針注射減少了與傳統針疫苗相關的恐懼和焦慮，提高了患者的依從性，從而促進了市場成長。此外，人們越來越認知到流感對公共衛生的影響，也推動了疫苗的採用。 COVID-19 大流行凸顯了對可擴展、可獲取且高效的疫苗解決方案的需求，增加了人們對微針技術的興趣。強調全民免疫的運動增加了創新輸送系統的需求。

老年人口特別容易感染流感，需要更安全、更舒適的疫苗接種方法。此外，人們對家庭醫療保健解決方案的日益青睞與微針貼片的自我管理性質一致。它消除了銳器廢物，減少了對環境的影響以及對專門處理系統的需求。降低醫護人員被針刺傷的風險。此外，微針系統正用於某些應用，例如藥物輸送，廣泛的商業用途正在促進市場成長。

微針流感疫苗市場 - 關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032 年）每年將以 6.30% 左右的複合年成長率成長

根據產品類型細分，由於其在疫苗中的有效性，空心微針細分市場預計將在 2023 年顯示最大的市場佔有率。

根據疫苗類型細分，由於在病毒株中的應用更廣泛，四價流感疫苗細分市場將成為 2023 年領先的疫苗類型細分市場。

從應用細分來看，藥物傳輸領域是2023年領先的應用領域，主要是由於其更容易獲得和監管支持。

從地區來看，由於藥物輸送的研發投資不斷增加，北美成為 2023 年的主要收入來源。

微針流感疫苗市場-細分分析：

全球微針流感疫苗市場根據產品類型、疫苗類型、應用和地區進行細分。

市場依產品類型分為兩類：實心微針和空心微針。空心微針細分市場佔據主導地位。疫苗輸送的可靠性更高，推動了對空心微針的需求。

市場依疫苗類型分為兩類：四價流感疫苗和三價流感疫苗。四價流感疫苗市場占主導地位。四價流感疫苗可針對甲型和乙型流感病毒株提供保護，增加了細分市場的需求。

市場依應用分為三類：研究與臨床試驗、藥物傳遞等。預計藥物傳輸領域在預測期內將以最快的速度成長。微針在藥物傳輸方面的需求不斷成長，因為它們在疫苗傳輸方面更加高效、可靠且方便用戶使用，預計將推動該領域的成長。

微針流感疫苗市場-地理洞察

從地理來看，該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太、中東和非洲等地區。在北美，由於強勁的研發資金、生技公司的存在以及監管支持，美國在該市場佔據主導地位。高認知度、先進的醫療基礎設施以及對創新疫苗解決方案的需求。此外，微針技術的臨床試驗和 FDA 批准的投資也在增加。在歐洲，德國、法國和英國在採用創新疫苗技術方面處於領先地位。在亞太地區，中國、日本和印度顯示出巨大的成長潛力。

微針流感疫苗市場-競爭格局：

微針流感疫苗市場性質溫和，並隨著製藥業的發展而迅速發展。該市場是由無痛疫苗輸送技術的創新所驅動的。微針技術因其增強疫苗可及性的潛力而得到越來越多的認可，特別是在偏遠或資源有限的環境中。公司正在大力投資先進材料和設計，以提高效率並降低成本。多家公司已與世界衛生組織或蓋茲基金會合作，在低收入國家分發。一些頂級企業正在亞太地區建立製造工廠，以滿足不斷成長的需求。

2023 年，Vaxxas 獲得了 BARDA（生物醫學高級研究與發展局）等機構的資助，用於推進和開發流感疫苗微針貼片。

2022 年 11 月，美光生物醫學公司獲得 1,400 萬美元投資，用於支持其商業製造。

目錄

第1章：微針流感疫苗市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按產品類型分類的微針流感疫苗市場片段
    • 按疫苗類型分類的微針流感疫苗市場片段
    • 微針流感疫苗市場片段（依應用）
    • 微針流感疫苗市場片段（按國家/地區）
    • 按地區分類的微針流感疫苗市場片段
  • 競爭洞察

第 3 章：微針流感疫苗主要市場趨勢

  • 微針流感疫苗市場促進因素
    • 市場促進因素的影響分析
  • 微針流感疫苗市場限制
    • 市場限制影響分析
  • 微針流感疫苗市場機會
  • 微針流感疫苗市場未來趨勢

第 4 章：微針流感疫苗產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：微針流感疫苗市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：微針流感疫苗市場格局

  • 2023 年微針流感疫苗市佔率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：微針流感疫苗市場 - 依產品類型

  • 概述
    • 按產品類型分類的細分市場佔有率分析
    • 實心微針
    • 空心微針

第 8 章：微針流感疫苗市場 - 依疫苗類型

  • 概述
    • 按疫苗類型分類的細分市場佔有率分析
    • 四價流感疫苗
    • 三價流感疫苗

第 9 章：微針流感疫苗市場 - 按應用

  • 概述
    • 按應用分類的細分市場佔有率分析
    • 研究與臨床試驗
    • 藥物輸送
    • 其他

第 10 章：微針流感疫苗市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美微針流感疫苗主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按產品類型）
    • 北美市場規模和預測（按疫苗類型）
    • 北美市場規模和預測（按應用）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲微針流感疫苗主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模和預測（按產品類型）
    • 歐洲市場規模和預測（按疫苗類型）
    • 歐洲市場規模和預測（按應用）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區微針流感疫苗主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（依產品類型）
    • 亞太地區市場規模與預測（依疫苗類型）
    • 亞太地區市場規模與預測（按應用）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲微針流感疫苗主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按產品類型）
    • 拉丁美洲市場規模與預測（按疫苗類型）
    • 拉丁美洲市場規模與預測（按應用）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲微針流感疫苗主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按產品類型）
    • 中東和非洲市場規模及預測（按疫苗類型）
    • 中東和非洲市場規模及預測（按應用）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 11 章：主要供應商分析-微針流感疫苗產業

  • 競爭儀表板
  • 公司簡介
    • 3M Drug Delivery Systems
    • Becton, Dickinson, and Company
    • Micron Biomedical Inc.
    • NanoPass Technologies
    • Vaxxas
    • Zosano Pharma Corporation
    • Corium, Inc.
    • TheraJect
    • Verndari, Inc.
    • Inovio Pharmaceuticals, Inc.
    • Xiamen Innovax Biotech Co., Ltd.
    • BioSerenTach
    • Transdermal Specialties, Inc.
    • EmulTech BV
    • Clearside Biomedical, Inc.
    • Others

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV4221

REPORT HIGHLIGHT

Microneedle Flu Vaccine Market Application was valued at USD 1,630.43 Million in 2023, expanding at a CAGR of 6.30% from 2024 to 2032.

The microneedle flu vaccine is an innovative approach to delivering influenza vaccines using microneedles, which are tiny needles typically smaller than a millimeter embedded in a small patch or device. This technology is designed to make vaccination easier, less painful, and potentially more accessible compared to traditional syringe-based methods.

Microneedle Flu Vaccine Market- Market Dynamics

Increasing demand for enhanced vaccine delivery & needle-free administration is expected to propel market demand

Microneedle flu vaccination provides enhanced immune response through intradermal delivery. Increased interest in more effective and patient-friendly vaccine technologies. Needle-free administration reduces fear and anxiety associated with traditional needle-based vaccines, increasing patient compliance, thereby boosting market growth. Also, increasing recognition of influenza's public health impact drives vaccine adoption. The COVID-19 pandemic highlighted the need for scalable, accessible, and efficient vaccine solutions, increasing interest in microneedle technology. Campaigns emphasizing universal immunization boost demand for innovative delivery systems.

Older adult population, particularly vulnerable to influenza, requires safer and more comfortable vaccination methods. Further, the growing preference for home healthcare solutions aligns with the self-administered nature of microneedle patches. It eliminates sharps waste, reducing environmental impact and the need for specialized disposal systems. Lowers the risk of needle-stick injuries for healthcare workers. Furthermore, microneedle systems are being used for certain applications such as drug delivery, and widespread commercial use is contributing to market growth.

Microneedle Flu Vaccine Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.30% over the forecast period (2024-2032)

Based on Product Type segmentation, the hollow microneedle segment was predicted to show maximum market share in 2023, owing to their effectiveness in vaccines.

Based on Vaccine Type segmentation, the quadrivalent flu vaccine segment was the leading Vaccine Type segment in 2023, due to wider applications in virus strains.

Based on application segmentation, the drug delivery segment was the leading application segment in 2023, mainly due to its greater accessibility and regulatory support.

On the basis of region, North America was the leading revenue generator in 2023, due to the increasing R&D investment in drug delivery.

Microneedle Flu Vaccine Market- Segmentation Analysis:

Global Microneedle Flu Vaccine Market is segmented on the basis of Product Type, Vaccine Type, Application, and Region.

The market is divided into two categories based on the Product Type: solid microneedle and hollow microneedle. The hollow microneedle segment dominates the market. The greater reliability in delivering the vaccine is boosting demand for hollow microneedle.

The market is divided into two categories based on Vaccine Type: quadrivalent flu vaccine and trivalent flu vaccine. The quadrivalent flu vaccine segment dominates the market. The quadrivalent flu vaccine provides protection against influenza A & B strains, increasing segment demand.

The market is divided into three categories based on Application: research & clinical trials, drug delivery, and others. The drug delivery segment is anticipated to grow at the fastest rate over the forecast period. The growing demand for microneedles in drug delivery as they are more efficient & reliable in vaccine deliverables & user-friendly is expected to fuel segment growth.

Microneedle Flu Vaccine Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. In North America, the U.S. dominates this market due to robust R&D funding, presence of biotech firms, and regulatory support. High awareness, advanced healthcare infrastructure, and demand for innovative vaccine solutions. Also, there is increasing investment in clinical trials and FDA approvals for microneedle technology. In Europe, Germany, France, and the UK lead in adopting innovative vaccine technologies. In Asia Pacific region, China, Japan, and India show significant growth potential opportunities.

Microneedle Flu Vaccine Market- Competitive Landscape:

The Microneedle Flu Vaccine market is moderately in nature and is rapidly evolving with pharma industry. The market is driven by innovations in painless vaccine delivery technologies. Microneedle technology is being increasingly recognized for its potential to enhance vaccine accessibility, particularly in remote or resource-limited settings. Companies are heavily investing in advanced materials and designs for higher efficacy and lower costs. Several companies have partnered with WHO or Gates Foundation for distribution in low-income countries. Some of the top players are building manufacturing units in Asia-Pacific to meet growing demand.

In 2023, Vaxxas have received grants from agencies like BARDA (Biomedical Advanced Research and Development Authority) to advance & develop flu vaccine microneedle patches.

In November 2022, Micron Biomedical, Inc. received USD 14 million through their investment to bolster its commercial manufacturing.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL MICRONEEDLE FLU VACCINE MARKET KEY PLAYERS

  • 3M Drug Delivery Systems
  • Becton, Dickinson, and Company
  • Micron Biomedical Inc.
  • NanoPass Technologies
  • Vaxxas
  • Zosano Pharma Corporation
  • Corium, Inc.
  • TheraJect
  • Verndari, Inc.
  • Inovio Pharmaceuticals, Inc.
  • Xiamen Innovax Biotech Co., Ltd.
  • BioSerenTach
  • Transdermal Specialties, Inc.
  • EmulTech BV
  • Clearside Biomedical, Inc.
  • Others

GLOBAL MICRONEEDLE FLU VACCINE MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019-2032

  • Solid microneedle
  • Hollow microneedle

GLOBAL MICRONEEDLE FLU VACCINE MARKET, BY VACCINE TYPE- MARKET ANALYSIS, 2019-2032

  • Quadrivalent flu vaccine
  • Trivalent flu vaccine

GLOBAL MICRONEEDLE FLU VACCINE MARKET, BY APPLICATION- MARKET ANALYSIS, 2019-2032

  • Research & clinical trials
  • Drug delivery
  • Others

GLOBAL MICRONEEDLE FLU VACCINE MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Microneedle Flu Vaccine Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Microneedle Flu Vaccine Market Snippet by Product Type
    • 2.1.2. Microneedle Flu Vaccine Market Snippet by Vaccine Type
    • 2.1.3. Microneedle Flu Vaccine Market Snippet by Application
    • 2.1.4. Microneedle Flu Vaccine Market Snippet by Country
    • 2.1.5. Microneedle Flu Vaccine Market Snippet by Region
  • 2.2. Competitive Insights

3. Microneedle Flu Vaccine Key Market Trends

  • 3.1. Microneedle Flu Vaccine Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Microneedle Flu Vaccine Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Microneedle Flu Vaccine Market Opportunities
  • 3.4. Microneedle Flu Vaccine Market Future Trends

4. Microneedle Flu Vaccine Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Microneedle Flu Vaccine Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Microneedle Flu Vaccine Market Landscape

  • 6.1. Microneedle Flu Vaccine Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Microneedle Flu Vaccine Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
    • 7.1.2. Solid microneedle
    • 7.1.3. Hollow microneedle

8. Microneedle Flu Vaccine Market - By Vaccine Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Vaccine Type, 2024 & 2032 (%)
    • 8.1.2. Quadrivalent flu vaccine
    • 8.1.3. Trivalent flu vaccine

9. Microneedle Flu Vaccine Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 9.1.2. Research & clinical trials
    • 9.1.3. Drug delivery
    • 9.1.4. Others

10. Microneedle Flu Vaccine Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Microneedle Flu Vaccine Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Microneedle Flu Vaccine Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Microneedle Flu Vaccine Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Microneedle Flu Vaccine Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Microneedle Flu Vaccine Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Microneedle Flu Vaccine Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. 3M Drug Delivery Systems
    • 11.2.2. Becton, Dickinson, and Company
    • 11.2.3. Micron Biomedical Inc.
    • 11.2.4. NanoPass Technologies
    • 11.2.5. Vaxxas
    • 11.2.6. Zosano Pharma Corporation
    • 11.2.7. Corium, Inc.
    • 11.2.8. TheraJect
    • 11.2.9. Verndari, Inc.
    • 11.2.10. Inovio Pharmaceuticals, Inc.
    • 11.2.11. Xiamen Innovax Biotech Co., Ltd.
    • 11.2.12. BioSerenTach
    • 11.2.13. Transdermal Specialties, Inc.
    • 11.2.14. EmulTech BV
    • 11.2.15. Clearside Biomedical, Inc.
    • 11.2.16. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us